Citadel Advisors
AGN

Citadel Advisors’s Allergan Inc AGN Stock Holding History

Citadel Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-708,361
Closed -$151M – 9377
2014
Q4 		$151M Sell
708,361
-417,015
-37% -$82.9M 0.15% 102
2014
Q3 		$201M Buy
1,125,376
+639,020
+131% +$106M 0.21% 69
2014
Q2 		$82.3M Sell
486,356
-561,884
-54% -$87.5M 0.09% 214
2014
Q1 		$130M Sell
1,048,240
-1,282,942
-55% -$156M 0.15% 110
2013
Q4 		$259M Buy
2,331,182
+1,757,098
+306% +$168M 0.34% 27
2013
Q3 		$51.9M Sell
574,084
-290,716
-34% -$26.1M 0.08% 301
2013
Q2 		$72.9M Buy
+864,800
New +$89.7M 0.13% 172

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Citadel Advisors's AGN Position: Q1 2015 in Review

Citadel Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 708,361 shares — an estimated $151M sold.

Citadel Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $259M in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Citadel Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Citadel Advisors sold 708,361 Allergan Inc shares in Q1 2015, an estimated $151M.
  • Citadel Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Citadel Advisors's Allergan Inc position peaked at $259M in Q4 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Citadel Advisors's 13F filing for Q1 2015, filed 15 May 2015.